AktiVax
About:
AktiVaxTM develops novel reconstitution and safety syringes for vaccines and biologics.
Website: http://www.aktivax.com
Description:
AktiVaxTM is creating a paradigm shift in vaccine delivery that will solve vaccine partners’ problems, costs, and complexities by providing an alternative to the traditional syringe and vial system. AktiVax’s solution involves a three-pillared approach: expertise in cost-effective, dry vaccine formulation; differentiated delivery devices; and efficient manufacturing for rapid market distribution. Our proposition has already attracted a number of vaccine partners representing a significant portion of the $30 billion vaccine industry. We believe that our solution will create a new standard of care in the vaccine market.
$515000
$1M to $10M
Aurora, Colorado, United States
2008-01-01
info(AT)aktivax.com
Amir Genosar
1-10
2012-03-21
Private
© 2025 bioDAO.ai